Physician Perspectives on Omitting Pelvic Lymph Node Dissection during Radical Prostatectomy for Intermediate to High-Risk Prostate Cancer Patients with Negative PSMA PET

Pelvic Lymph node dissection (PLND) during radical prostatectomy (RP) remains a topic of ongoing debate in the management of prostate cancer (PCa). There is increasing evidence that PLND may have limited utility for staging purposes especially with the advent of PSMA PET/CT scan.

This global survey aims to capture the current practices regarding PLND for Pca.

Physicians are invited to complete this short (6-minute) online survey.

By participating, you consent to the processing of your personal data in accordance with Art. 13 of Legislative Decree 196/2003 and Art. 13 of the GDPR (Reg. EU 2016/679).